Physician

Ravi Patel, M.D.

According to 2025 Medicare claims, Ravi Patel, M.D. (NPI: 1386631901) practices hematology/oncology in the Bakersfield-Delano, CA market, with the plurality of this provider's patient population coming from Kern, CA. This provider's primary affiliated billing organization is RAVI PATEL M.D. INC (NPI: 1912978834; TIN: 770356364) and primary practice location at 93309-0633. Patel is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,118 traditional Medicare patients, billed 86,927 HCPCS/CPT codes, and received $1,625,523 in Medicare payments. The top billing code was 80053 (Blood test, comprehensive group of blood chemicals). Part D data shows 1,051 prescription claims across 199 beneficiaries totaling $2,310,414 in drug costs, led by Verzenio (Abemaciclib). DME data shows 377 claims. Open Payments data shows 50 records totaling $94,219. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $2,438,334 to $1,625,523. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,725,570 and ending at $2,310,414. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $16,745 and ending at $12,219.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,357	126,630	$2,438,334
2016	1,152	109,100	$2,154,668
2017	1,059	103,152	$2,295,874
2018	1,044	116,941	$2,845,810
2019	1,072	121,643	$2,648,370
2020	924	94,878	$1,906,005
2021	976	97,413	$2,106,183
2022	1,058	106,616	$2,112,069
2023	1,259	106,039	$2,055,861
2024	1,118	86,927	$1,625,523

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	279	1,970	$1,725,570
2016	299	1,905	$1,297,245
2017	246	1,488	$967,340
2018	268	1,636	$861,203
2019	299	1,733	$1,870,038
2020	255	1,634	$1,928,624
2021	352	2,037	$2,200,471
2022	233	981	$1,719,171
2023	201	842	$1,643,681
2024	199	1,051	$2,310,414

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	39	252	$31,090
2016	14	165	$25,201
2017	13	146	$14,028
2018	64	245	$36,955
2019	76	350	$24,045
2020	29	309	$19,431
2021	N/R	172	$7,222
2022	35	162	$6,345
2023	N/R	125	$35,771
2024	13	377	$119,177

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80053	Blood test, comprehensive group of blood chemicals	704	3,187	$10
36415	Insertion of needle into vein for collection of blood sample	711	2,706	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	717	3,631	$8
83615	Lactate dehydrogenase (enzyme) level	656	3,334	$6
84550	Uric acid level, blood	656	3,333	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	32	896	$483,038
Xtandi	Enzalutamide	28	840	$344,661
Ibrance	Palbociclib	13	364	$204,038
Mekinist	Trametinib Dimethyl Sulfoxide	12	360	$184,487
Tafinlar	Dabrafenib Mesylate	12	360	$169,922

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4193	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix	N	N/R	53	$45,369
B4197	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix	N	N/R	17	$36,965
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	72	$21,068
B4224	Parenteral nutrition administration kit, per day	N	N/R	72	$8,604
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	71	$2,728

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$573	Exelixis Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	18	$93,646	Mirati Therapeutics, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ravi Patel, M.D.?

Tedicare shows public-source Medicare data for Ravi Patel, M.D. (NPI 1386631901), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ravi Patel, M.D. have ACO affiliation data?

Ravi Patel, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Ravi Patel, M.D.?

Ravi Patel, M.D. is linked to RAVI PATEL M.D. INC (billing NPI 1912978834) in the available physician profile data.

Does Ravi Patel, M.D. have Open Payments data?

Ravi Patel, M.D. has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.